Scribe Develops a Unique and Customized EHR Interface to Consolidate Patient Documentation

The integration team at Scribe Healthcare Technologies, Inc. (http://www.scribe.com) has successfully completed hundreds of integrations, working with the full gamut of Electronic Medical Record/Electronic Health Record (EMR/EHR) systems, but none to date have offered the uniqueness of a recent project.

When medical transcription company Global Info Systems joined Scribe’s medical dictation, transcription and documentation improvement platforms, they presented an extraordinary challenge regarding the most effective way to service a multitude of oncologists. Providing medical transcription and patient documentation for over 160 oncology clinics involved typing directly into iKnowMed, an oncology EHR. This is not only somewhat cumbersome for the transcriptionists but difficult to manage effectively. “Our Texas Oncology Implementation is a partnership with a wide variety of clinics, each with many physicians,” said Venu Vankarla, Technology Consultant for Global Info Systems. “The physicians move from clinic to clinic, so we needed an infrastructure to support the entire patient workflow processes while safeguarding clinic workflow preferences.”

The implementation process for both Scribe and Global Info Systems involved progressively adding a notable number of clinics while the oncologists continued to capture and house their patients’ intricate histories exclusively in the iKnowMed EHR. Concurrently, it was imperative that Global Info Systems’ teams of medical transcriptionists continue to deliver high-quality and timely clinical documentation with a more flexible and cost-effective system. They looked to Scribe for a complete solution that enabled detailed data capture, comprehensive documentation management, and assimilation with strategic partner iKnowMed EHR.

To streamline their workflow, Scribe’s Integration Team developed an especially customized system that combines audio and text information to assist Global Info Systems in creating accurate documentation throughout the entire patient-care process. “This is the first time one of our medical transcription company clients has had all of the patient information consolidated from a transcription and management perspective,” explained Mark Boyce, CEO for Scribe. “Furthermore, the schedule information and documentation is sent via a technology protocol we typically don’t use, which made this integration totally different from all other systems.”

The tailored integration also includes significant customer reports to help Global Info Systems manage documentation and assist their Practice/Clinic Managers in optimizing physician and patient encounters. The reporting compares visit schedules and dictation logs to help maintain consistent but flexible workflow policies as the patient documentation evolves. “The reporting capabilities have been beneficial and help us manage our team of transcription professionals,” remarked Linda Allen, Senior Manager/QA Manager for Global Info Systems. “Having all of the transcribed reports in one place enables us to monitor turnaround time for our clients more effectively.”

Although Scribe Integrations remain transparent by operating completely in the background, the systems’ ability to ensure accurate clinical documentation is quite visible. Whether it is a standard integration or complex program, Scribe’s Integrations take various stages of the patient encounter and simplify them into one cohesive process to enhance patient care.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.